Maryam Tajabadi Ebrahimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maryam Tajabadi Ebrahimi has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Seyed Naser Mousavi
Department of Animal Science Varamin‐Pishva Branch Islamic Azad University Varamin Iran
3 shared publications- Abbas Akhavan Sepahi
Department of Microbiology, Faculty of Basic Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran
2 shared publications - Abbas Yadegar
Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications - Alireza Iranbakhsh
Institute of Converging sciences and Technologies, SR.C., Islamic Azad University, Tehran, Iran
2 shared publications - Fatemeh Adami Ghamsari
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2 shared publications Mandana Salehizadeh
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 5 June 2026
- Published by Walter de Gruyter GmbH in Annals of Animal Science
Effect of Bacillus subtilis probiotics (live vs. pressure-killed) on growth performance, immune function, and biochemical indices in the rainbow trout, Oncorhynchus mykiss
The effects of different dietary probiotics, Bacillus subtilis as live and killed (paraprobiotic) and their combination, were assessed in the current research on the growth, immunity, antioxidant system, and some serum biochemical parameters in rainbow trout, Oncorhynchus mykiss . The fish were fed for 60 days across four treatment groups, each in three replicates. The diets included: 1) control diet: basal commercial diet, 2) probiotic (PRO): diet containing 1.5 × 10 6 CFU/g live Bacillus subtilis , 3) PAR: diet containing 1.5 × 10 6 CFU/g pressure-killed Bacillus subtilis (paraprobiotic or PAR) and 4) a combination of PRO + PAR. The growth and biochemical parameters were analyzed on days 30 and 60 of the study. Based on the findings, use of PRO and PAR in combination significantly improved growth performance (P50 ) activities, as well as immunoglobulin (IgM) level, compared to the control group (PBacillus spp. count (BAC) exhibited an increase following PRO and PAR supplementation in the diet (PBacillus subtilis on growth, immune function, and overall health of rainbow trout. The data also indicate that the most favorable outcomes were achieved when both supplements were administered together, demonstrating their combined benefits.
- 5 June 2026
- Published by Walter de Gruyter GmbH in Annals of Animal Science
Open AccessEffect of Bacillus subtilis probiotics (live vs. pressure-killed) on growth performance, immune function, and biochemical indices in the rainbow trout, Oncorhynchus mykiss
The effects of different dietary probiotics, Bacillus subtilis as live and killed (paraprobiotic) and their combination, were assessed in the current research on the growth, immunity, antioxidant system, and some serum biochemical parameters in rainbow trout, Oncorhynchus mykiss . The fish were fed for 60 days across four treatment groups, each in three replicates. The diets included: 1) control diet: basal commercial diet, 2) probiotic (PRO): diet containing 1.5 × 10 6 CFU/g live Bacillus subtilis , 3) PAR: diet containing 1.5 × 10 6 CFU/g pressure-killed Bacillus subtilis (paraprobiotic or PAR) and 4) a combination of PRO + PAR. The growth and biochemical parameters were analyzed on days 30 and 60 of the study. Based on the findings, use of PRO and PAR in combination significantly improved growth performance (P50 ) activities, as well as immunoglobulin (IgM) level, compared to the control group (PBacillus spp. count (BAC) exhibited an increase following PRO and PAR supplementation in the diet (PBacillus subtilis on growth, immune function, and overall health of rainbow trout. The data also indicate that the most favorable outcomes were achieved when both supplements were administered together, demonstrating their combined benefits.
- Open Access
- 15 October 2025
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 13 (10) , e70285
Pathogenic Potential of Invasive Mucosa‐Associated Klebsiella pneumoniae Isolates in Ulcerative Colitis: Characterization of Virulence Factors and Inflammatory Response
Background: Klebsiella pneumoniae has emerged as an opportunistic pathobiont potentially exacerbating ulcerative colitis (UC) through virulence‐mediated inflammation. However, the pathogenic role of invasive mucosa‐associated K. pneumoniae in UC remains underexplored. This study characterizes virulence factors and inflammatory responses in K. pneumoniae isolates from UC patients to elucidate their contribution to disease progression. Methods: Mucosa‐associated K. pneumoniae isolates ( n = 62) from UC patients were compared to non‐UC controls. Virulence genes, including kfu , magA , fimH , mrkD , rmpA , ybtS , iutA , iroN , hcp , and vgrG , were investigated via PCR. Adhesion, invasion, and intracellular survival were assessed in Caco‐2 and THP‐1 cells. The relative expression levels of the NOD1 , NOD2 , STAT1 , and NF‐κB genes were assessed using real‐time quantitative PCR. The concentrations of interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and interleukin‐8 (IL‐8) were quantified with enzyme‐linked immunosorbent assay (ELISA) kits. Results: UC‐associated K. pneumoniae isolates exhibited higher prevalence of adhesion/invasion genes (e.g., fimH in 77.4% vs. 46.6%) and enhanced adhesive/invasive phenotypes (29% adherent, 16.1% invasive) compared to controls. These strains lacked hypervirulence markers ( rmpA , magA ) but aligned with classical virulent profiles. Invasive isolates upregulated NOD1 , NOD2 , and STAT1 expression and significantly increased IL‐8 secretion ( p < 0.05), amplifying pro‐inflammatory responses. Conclusion: Invasive mucosa‐associated K. pneumoniae in UC display distinct virulence traits that promote epithelial invasion and inflammation, potentially driving disease exacerbation. Targeting these pathobionts offers a promising avenue for novel UC therapies.
- 15 October 2025
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 13 (10) , e70285
Open AccessPathogenic Potential of Invasive Mucosa‐Associated Klebsiella pneumoniae Isolates in Ulcerative Colitis: Characterization of Virulence Factors and Inflammatory Response
Background: Klebsiella pneumoniae has emerged as an opportunistic pathobiont potentially exacerbating ulcerative colitis (UC) through virulence‐mediated inflammation. However, the pathogenic role of invasive mucosa‐associated K. pneumoniae in UC remains underexplored. This study characterizes virulence factors and inflammatory responses in K. pneumoniae isolates from UC patients to elucidate their contribution to disease progression. Methods: Mucosa‐associated K. pneumoniae isolates ( n = 62) from UC patients were compared to non‐UC controls. Virulence genes, including kfu , magA , fimH , mrkD , rmpA , ybtS , iutA , iroN , hcp , and vgrG , were investigated via PCR. Adhesion, invasion, and intracellular survival were assessed in Caco‐2 and THP‐1 cells. The relative expression levels of the NOD1 , NOD2 , STAT1 , and NF‐κB genes were assessed using real‐time quantitative PCR. The concentrations of interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and interleukin‐8 (IL‐8) were quantified with enzyme‐linked immunosorbent assay (ELISA) kits. Results: UC‐associated K. pneumoniae isolates exhibited higher prevalence of adhesion/invasion genes (e.g., fimH in 77.4% vs. 46.6%) and enhanced adhesive/invasive phenotypes (29% adherent, 16.1% invasive) compared to controls. These strains lacked hypervirulence markers ( rmpA , magA ) but aligned with classical virulent profiles. Invasive isolates upregulated NOD1 , NOD2 , and STAT1 expression and significantly increased IL‐8 secretion ( p < 0.05), amplifying pro‐inflammatory responses. Conclusion: Invasive mucosa‐associated K. pneumoniae in UC display distinct virulence traits that promote epithelial invasion and inflammation, potentially driving disease exacerbation. Targeting these pathobionts offers a promising avenue for novel UC therapies.
- 20 May 2025
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 131 (6) , 907-917
The impact of a multi-species probiotic supplementation on clinical symptoms and biochemical factors in patients with irritable bowel syndrome: a randomised controlled trial
Background: Intestinal inflammation and oxidative stress contribute to the pathophysiology of irritable bowel syndrome (IBS). This clinical trial investigated the effects of a probiotic supplementation on symptom severity and quality of life (QOL) in IBS patients. Methods: Forty-six IBS patients were randomised to receive either a multi-species probiotic or placebo for 8 weeks. Clinical symptoms were evaluated using the IBS Severity Scoring System (IBS-SSS) and IBS QOL questionnaire. Serum levels of IFN-γ, IL-1β, IL-10, IL-6, malondialdehyde (MDA), total antioxidant capacity (TAC), and nitric oxide (NO) were measured before and after the intervention. Results: After 8 weeks, the probiotic group showed significant improvements in QOL scores, and reductions in IBS-SSS and MDA levels compared to placebo group. TAC levels were significantly higher in probiotic group. However, no significant differences were observed in cytokine or NO levels. Conclusions: This multi-species probiotic supplement was safe and effective in reducing symptom severity and improved QOL of IBS patients.
- 20 May 2025
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 131 (6) , 907-917
The impact of a multi-species probiotic supplementation on clinical symptoms and biochemical factors in patients with irritable bowel syndrome: a randomised controlled trial
Background: Intestinal inflammation and oxidative stress contribute to the pathophysiology of irritable bowel syndrome (IBS). This clinical trial investigated the effects of a probiotic supplementation on symptom severity and quality of life (QOL) in IBS patients. Methods: Forty-six IBS patients were randomised to receive either a multi-species probiotic or placebo for 8 weeks. Clinical symptoms were evaluated using the IBS Severity Scoring System (IBS-SSS) and IBS QOL questionnaire. Serum levels of IFN-γ, IL-1β, IL-10, IL-6, malondialdehyde (MDA), total antioxidant capacity (TAC), and nitric oxide (NO) were measured before and after the intervention. Results: After 8 weeks, the probiotic group showed significant improvements in QOL scores, and reductions in IBS-SSS and MDA levels compared to placebo group. TAC levels were significantly higher in probiotic group. However, no significant differences were observed in cytokine or NO levels. Conclusions: This multi-species probiotic supplement was safe and effective in reducing symptom severity and improved QOL of IBS patients.
- Top Cited PapersOpen Access
- 15 January 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (1) , e70199
Transforming Feather Meal Into a High‐Performance Feed for Broilers
Background: The poultry industry faces challenges with the high cost and environmental impact of Soybean meal. Feather meal, a byproduct with low digestibility due to its keratin content, is a potential alternative. Recent biotechnological advances, including enzymatic and bacterial hydrolysis, have enhanced its digestibility and nutritional value.Objective: This study aimed to evaluate and compare the efficacy of three different feather meal processing methods as partial replacements for soybean meal in broiler diets. The methods assessed included hydrolyzed feather meal treated with Streptomyces bacteria, commercial enzyme‐treated feather meal, and boiled feather meal. Their effects on performance and nutrient digestibility were evaluated in Ross 308 male broiler chickens.Materials: The study involved 525 Ross 308 male broiler chickens were allocated to seven dietary treatments, which included a control diet and varying combinations of feather meal and soybean meal. Streptomyces sp. MSM5 was shown to effectively produce keratinase, enhancing the amino acid content of the feather meal.Results: Birds fed diets containing 33% and 67% boiled feather meal exhibited significantly reduced body weight gain (BWG) and increased feed conversion ratio (FCR) compared to the control group (p < 0.05). In contrast, birds fed diets with 33% hydrolyzed feather meal, treated with either enzymes or bacteria, showed similar BWG and FCR to those on the control diet. However, diets with 67% hydrolyzed feather meal led to significant reductions in performance (p < 0.05).Additionally, diets containing 33% and 67% boiled feather meal, as well as 67% hydrolyzed feather meal, resulted in significantly lower carcass percentage, breast muscle percentage, thigh muscle percentage, overall dry matter digestibility, and protein digestibility (p < 0.05).Conclusion: The results indicate that substituting as much as 33% of soybean meal with processed feather meal, particularly when treated with enzymes or bacteria, does not negatively impact broiler performance. Furthermore, the results underscore the potential of biotechnological treatments, such as bacterial keratin hydrolysis, to enhance the nutritional value of feather meal, transforming it into a high‐quality, sustainable protein source for the poultry industry.
- 15 January 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (1) , e70199
Top Cited PapersOpen AccessTransforming Feather Meal Into a High‐Performance Feed for Broilers
Background: The poultry industry faces challenges with the high cost and environmental impact of Soybean meal. Feather meal, a byproduct with low digestibility due to its keratin content, is a potential alternative. Recent biotechnological advances, including enzymatic and bacterial hydrolysis, have enhanced its digestibility and nutritional value.Objective: This study aimed to evaluate and compare the efficacy of three different feather meal processing methods as partial replacements for soybean meal in broiler diets. The methods assessed included hydrolyzed feather meal treated with Streptomyces bacteria, commercial enzyme‐treated feather meal, and boiled feather meal. Their effects on performance and nutrient digestibility were evaluated in Ross 308 male broiler chickens.Materials: The study involved 525 Ross 308 male broiler chickens were allocated to seven dietary treatments, which included a control diet and varying combinations of feather meal and soybean meal. Streptomyces sp. MSM5 was shown to effectively produce keratinase, enhancing the amino acid content of the feather meal.Results: Birds fed diets containing 33% and 67% boiled feather meal exhibited significantly reduced body weight gain (BWG) and increased feed conversion ratio (FCR) compared to the control group (p < 0.05). In contrast, birds fed diets with 33% hydrolyzed feather meal, treated with either enzymes or bacteria, showed similar BWG and FCR to those on the control diet. However, diets with 67% hydrolyzed feather meal led to significant reductions in performance (p < 0.05).Additionally, diets containing 33% and 67% boiled feather meal, as well as 67% hydrolyzed feather meal, resulted in significantly lower carcass percentage, breast muscle percentage, thigh muscle percentage, overall dry matter digestibility, and protein digestibility (p < 0.05).Conclusion: The results indicate that substituting as much as 33% of soybean meal with processed feather meal, particularly when treated with enzymes or bacteria, does not negatively impact broiler performance. Furthermore, the results underscore the potential of biotechnological treatments, such as bacterial keratin hydrolysis, to enhance the nutritional value of feather meal, transforming it into a high‐quality, sustainable protein source for the poultry industry.
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 31 (3) , 233-242
Improving Vaccine Response through Probiotics and Micronutrient Supplementation: Evaluating the Role of TLR5 in Adult Female BALB/c Mice
Background: The role of probiotics and micronutrients in improving immune system function and response to vaccination has been proven. Hence, this study aimed to investigate the effects of probiotics enriched with micronutrients on the immunogenicity of PastoCovac® vaccine. Methods: The probiotic supplement BioBoost® and PastoCovac® vaccine, which contain six expressed Receptor- binding Domains (RBD) and conjugated with tetanus toxin, were administered concurrently. The safety and efficacy were assessed by determining Immunoglobulin G (IgG) antibody titers to RBD and cytokines, mRNA expression of Toll-like Receptors (TLRs) 5, and clinical symptoms. Results: Results revealed that the administration of the probiotics enriched with micronutrients and vitamins for 14 days before the first vaccine dose, followed by continued supplementation for 14 days after the first dose, and in conjunction with the second vaccine dose, yielded the most significant elevation in Interleukin 4 (IL-4), Tumor Necrosis Factor-alpha (TNF alpha), Interferon-gamma (IFN-gamma), and anti-SARS-CoV-2 RBD IgG levels within the supernatant samples collected from spleen cultures with the highest expression of TLR5 genes in intestinal samples, compared to the control group. Conclusion: Our results indicated that the inclusion of probiotics enriched with micronutrients and vitamins significantly enhanced the immunogenicity of the PastoCovac® vaccine. Based on the recommendation to administer third and fourth vaccine doses, particularly for vulnerable and elderly individuals, the utilization of supplements containing probiotics is expected to favorably influence immune responses.
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 31 (3) , 233-242
Improving Vaccine Response through Probiotics and Micronutrient Supplementation: Evaluating the Role of TLR5 in Adult Female BALB/c Mice
Background: The role of probiotics and micronutrients in improving immune system function and response to vaccination has been proven. Hence, this study aimed to investigate the effects of probiotics enriched with micronutrients on the immunogenicity of PastoCovac® vaccine. Methods: The probiotic supplement BioBoost® and PastoCovac® vaccine, which contain six expressed Receptor- binding Domains (RBD) and conjugated with tetanus toxin, were administered concurrently. The safety and efficacy were assessed by determining Immunoglobulin G (IgG) antibody titers to RBD and cytokines, mRNA expression of Toll-like Receptors (TLRs) 5, and clinical symptoms. Results: Results revealed that the administration of the probiotics enriched with micronutrients and vitamins for 14 days before the first vaccine dose, followed by continued supplementation for 14 days after the first dose, and in conjunction with the second vaccine dose, yielded the most significant elevation in Interleukin 4 (IL-4), Tumor Necrosis Factor-alpha (TNF alpha), Interferon-gamma (IFN-gamma), and anti-SARS-CoV-2 RBD IgG levels within the supernatant samples collected from spleen cultures with the highest expression of TLR5 genes in intestinal samples, compared to the control group. Conclusion: Our results indicated that the inclusion of probiotics enriched with micronutrients and vitamins significantly enhanced the immunogenicity of the PastoCovac® vaccine. Based on the recommendation to administer third and fourth vaccine doses, particularly for vulnerable and elderly individuals, the utilization of supplements containing probiotics is expected to favorably influence immune responses.
- 28 May 2024
- Published by Springer Nature in Psychopharmacology
- Vol. 241 (9) , 1905-1914
Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson’s disease: a randomized controlled clinical trial
Rationale Probiotics have beneficial effects on the nervous system by modulating the gut-brain axis. Additionally, vitamin D supplementation presents a potential way for ameliorating neuropsychological disorders, particularly in regions with a high prevalence of vitamin D deficiency. Objectives The current clinical trial aimed to investigate the role of co-administered supplementation of probiotics and Vitamin D on the different inflammatory aspects of patients with Parkinson’s disease. Methods Forty-six patients with PD were recruited From the Functional Neurosurgery Research Center, Tehran, Iran. These patients were randomly allocated to one of the two treatment groups: Group A, who received probiotic/vitamin D supplements (n = 23), and Group B who received placebo capsules (n = 23) for 12 weeks. As primary outcomes, Interferon-Gamma (IFN-γ), interleukin 1 beta (IL-1β), IL-6, IL-10, Tumor Necrosis Factor-Alpha (TNF-α), total antioxidant capacity (TAC), and malondialdehyde (MDA) in serum were evaluated at the baseline and the end of the trial. Moreover, Additional questionnaire-based factors including gastrointestinal symptom rating scale (GSRS), Beck Anxiety Inventory (BAI), and Unified Parkinson’s Disease Rating Scale (UPDRS) were evaluated. Results Our findings demonstrated that the consumption of probiotic/vitamin D supplements leads to a significant decrease in IL-1β, INF-γ, IL-6, and MDA levels, while showing a significant increase in IL-10 and TAC levels compared to the placebo group (P < 0.05). Additionally, it leads to a significant decrease in the disease severity, anxiety, and gastrointestinal problems in PD patients in comparison to the placebo group (P < 0.05). Conclusions Given the acknowledged role of inflammation in the pathogenesis of Parkinson’s disease on one hand, and the recognized anti-inflammatory and antioxidant effects associated with probiotics and vitamin D on the other hand, the concurrent administration of probiotics and vitamin D supplements emerges as a promising and potentially effective treatment option for individuals with PD.
- 28 May 2024
- Published by Springer Nature in Psychopharmacology
- Vol. 241 (9) , 1905-1914
Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson’s disease: a randomized controlled clinical trial
Rationale Probiotics have beneficial effects on the nervous system by modulating the gut-brain axis. Additionally, vitamin D supplementation presents a potential way for ameliorating neuropsychological disorders, particularly in regions with a high prevalence of vitamin D deficiency. Objectives The current clinical trial aimed to investigate the role of co-administered supplementation of probiotics and Vitamin D on the different inflammatory aspects of patients with Parkinson’s disease. Methods Forty-six patients with PD were recruited From the Functional Neurosurgery Research Center, Tehran, Iran. These patients were randomly allocated to one of the two treatment groups: Group A, who received probiotic/vitamin D supplements (n = 23), and Group B who received placebo capsules (n = 23) for 12 weeks. As primary outcomes, Interferon-Gamma (IFN-γ), interleukin 1 beta (IL-1β), IL-6, IL-10, Tumor Necrosis Factor-Alpha (TNF-α), total antioxidant capacity (TAC), and malondialdehyde (MDA) in serum were evaluated at the baseline and the end of the trial. Moreover, Additional questionnaire-based factors including gastrointestinal symptom rating scale (GSRS), Beck Anxiety Inventory (BAI), and Unified Parkinson’s Disease Rating Scale (UPDRS) were evaluated. Results Our findings demonstrated that the consumption of probiotic/vitamin D supplements leads to a significant decrease in IL-1β, INF-γ, IL-6, and MDA levels, while showing a significant increase in IL-10 and TAC levels compared to the placebo group (P < 0.05). Additionally, it leads to a significant decrease in the disease severity, anxiety, and gastrointestinal problems in PD patients in comparison to the placebo group (P < 0.05). Conclusions Given the acknowledged role of inflammation in the pathogenesis of Parkinson’s disease on one hand, and the recognized anti-inflammatory and antioxidant effects associated with probiotics and vitamin D on the other hand, the concurrent administration of probiotics and vitamin D supplements emerges as a promising and potentially effective treatment option for individuals with PD.
- Open Access
- 10 April 2024
- Published by Wiley in Neuropsychopharmacology Reports
- Vol. 44 (2) , 389-398
Co‐administration of probiotic and vitamin D significantly improves cognitive function in schizophrenic patients: A double‐blinded randomized controlled trial
Aim: Manipulation of the intestinal microbiome and supplying vitamin D can attenuate psychiatric symptoms in schizophrenic patients. The current study tried to evaluate the effects of probiotic/vitamin D supplementation on the cognitive function and disease severity of schizophrenic patients.Methods: In the present study, 70 patients (aged 18–65) with schizophrenia were recruited. Participants were randomly allocated to the placebo (n = 35) and intervention (probiotic supplements+400 IU vitamin D, n = 35) groups. Severity of disease and cognitive function (primary outcomes) were evaluated by Positive and Negative Syndrome Scale (PANSS) and Montreal Cognitive Assessment (MoCA) tests, respectively. Moreover, lipid profile, body mass index (BMI), gastrointestinal (GI) problems, serum C‐reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were evaluated as secondary outcomes.Results: A total of 69 patients completed the study. The MoCA score was increased by 1.96 units in the probiotic‐containing supplement group compared to the placebo (p = 0.004). Also, the percentage of subjects with MoCA score ≥ 26 rose significantly in the intervention group (p = 0.031). Moreover, TC (p = 0.011), FBS (p = 0.009), and CRP (p < 0.001) significantly decreased in the supplement group compared to the placebo. Although the probiotic supplement reduced PANSS score by 2.82 units, the difference between the study groups was not statistically significant (p = 0.247).Conclusion: Co‐administration of probiotics and vitamin D has beneficial effects on the improvement of cognitive function in schizophrenic patients.
- 10 April 2024
- Published by Wiley in Neuropsychopharmacology Reports
- Vol. 44 (2) , 389-398
Open AccessCo‐administration of probiotic and vitamin D significantly improves cognitive function in schizophrenic patients: A double‐blinded randomized controlled trial
Aim: Manipulation of the intestinal microbiome and supplying vitamin D can attenuate psychiatric symptoms in schizophrenic patients. The current study tried to evaluate the effects of probiotic/vitamin D supplementation on the cognitive function and disease severity of schizophrenic patients.Methods: In the present study, 70 patients (aged 18–65) with schizophrenia were recruited. Participants were randomly allocated to the placebo (n = 35) and intervention (probiotic supplements+400 IU vitamin D, n = 35) groups. Severity of disease and cognitive function (primary outcomes) were evaluated by Positive and Negative Syndrome Scale (PANSS) and Montreal Cognitive Assessment (MoCA) tests, respectively. Moreover, lipid profile, body mass index (BMI), gastrointestinal (GI) problems, serum C‐reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were evaluated as secondary outcomes.Results: A total of 69 patients completed the study. The MoCA score was increased by 1.96 units in the probiotic‐containing supplement group compared to the placebo (p = 0.004). Also, the percentage of subjects with MoCA score ≥ 26 rose significantly in the intervention group (p = 0.031). Moreover, TC (p = 0.011), FBS (p = 0.009), and CRP (p < 0.001) significantly decreased in the supplement group compared to the placebo. Although the probiotic supplement reduced PANSS score by 2.82 units, the difference between the study groups was not statistically significant (p = 0.247).Conclusion: Co‐administration of probiotics and vitamin D has beneficial effects on the improvement of cognitive function in schizophrenic patients.
- Open Access
- 20 January 2023
- Published by National Documentation Centre (EKT) in Journal of the Hellenic Veterinary Medical Society
- Vol. 73 (4) , 4891-4898
Effect of Adding an Organic Binder on Health of Cows Fed with Mycotoxins Contaminated Diet
Mycotoxins contamination occurring in dairy cow's diet is responsible for devastating effects on livestock health. Among different strategies, using organic adsorbents is a promising approach to reduce the toxicity of mycotoxins. This study investigated the effects of an organic adsorbent containing Lactobacillus brevis TD4, Lactobacillus paracasei TD3, and Saccharomyces cerevisiae cell wall on milk production, somatic cell count, blood parameters (white blood cell [WBC], lymphocyte [LYM], neutrophil, basophil, monocyte, eosinophil, red blood cell, haemoglobin, haematocrit, mean corpuscular volume, mean corpuscular haemoglobin) and liver function (alanine transaminase [ALT], gamma-glutamyl transferase [GGT], aspartate transaminase [AST], alkaline phosphatase [ALP], urea, total protein, albumin) in dairy cows fed a naturally contaminated diet with Zearalenone and Deoxynivalenol. The amounts of mycotoxins Zearalenone (ZEA) and Deoxynivalenol (DON) in feed ingredients were measured using the HPLC method. Ten Holstein dairy cows received organic adsorbents daily in their diets for four weeks. Milk and blood samples were taken from cows before the start of feeding adsorbent (CTRL), during the feeding period (FP), and one week after removal of adsorbent from the diet (RP). Totally, the amount of measured ZEA and DON toxins in the diet were 389 and 1254.6 ppb, respectively. Feeding of organic adsorbent significantly increased milk production, total serum protein, and albumin compared to CTRL (P<0.01). Also, numerically lower somatic cell count in their milk and a significant decrease (P<0.01) in serum urea were resulted. Among examined blood parameters, the number of WBC and LYM significantly decreased (P<0.01) after feeding with the organic binder in comparison to the control period. Furthermore, except for a significant increase in the level of AST (P<0.05), the other liver function examined parameters were not affected. The consumption of feed containing low-cost organic adsorbent including Lactobacillus bacteria and yeast cell wall can improve the physical condition and health of dairy cows and reduce economic losses in livestock production.
- 20 January 2023
- Published by National Documentation Centre (EKT) in Journal of the Hellenic Veterinary Medical Society
- Vol. 73 (4) , 4891-4898
Open AccessEffect of Adding an Organic Binder on Health of Cows Fed with Mycotoxins Contaminated Diet
Mycotoxins contamination occurring in dairy cow's diet is responsible for devastating effects on livestock health. Among different strategies, using organic adsorbents is a promising approach to reduce the toxicity of mycotoxins. This study investigated the effects of an organic adsorbent containing Lactobacillus brevis TD4, Lactobacillus paracasei TD3, and Saccharomyces cerevisiae cell wall on milk production, somatic cell count, blood parameters (white blood cell [WBC], lymphocyte [LYM], neutrophil, basophil, monocyte, eosinophil, red blood cell, haemoglobin, haematocrit, mean corpuscular volume, mean corpuscular haemoglobin) and liver function (alanine transaminase [ALT], gamma-glutamyl transferase [GGT], aspartate transaminase [AST], alkaline phosphatase [ALP], urea, total protein, albumin) in dairy cows fed a naturally contaminated diet with Zearalenone and Deoxynivalenol. The amounts of mycotoxins Zearalenone (ZEA) and Deoxynivalenol (DON) in feed ingredients were measured using the HPLC method. Ten Holstein dairy cows received organic adsorbents daily in their diets for four weeks. Milk and blood samples were taken from cows before the start of feeding adsorbent (CTRL), during the feeding period (FP), and one week after removal of adsorbent from the diet (RP). Totally, the amount of measured ZEA and DON toxins in the diet were 389 and 1254.6 ppb, respectively. Feeding of organic adsorbent significantly increased milk production, total serum protein, and albumin compared to CTRL (P<0.01). Also, numerically lower somatic cell count in their milk and a significant decrease (P<0.01) in serum urea were resulted. Among examined blood parameters, the number of WBC and LYM significantly decreased (P<0.01) after feeding with the organic binder in comparison to the control period. Furthermore, except for a significant increase in the level of AST (P<0.05), the other liver function examined parameters were not affected. The consumption of feed containing low-cost organic adsorbent including Lactobacillus bacteria and yeast cell wall can improve the physical condition and health of dairy cows and reduce economic losses in livestock production.
- 31 December 2020
- Published by Hindawi Limited in Journal of Food Processing and Preservation
- Vol. 45 (3)
In vitro reduction of mycotoxin deoxynivalenol by organic adsorbent
The contamination of feeds and foods with mycotoxins is a serious problem worldwide. Deoxynivalenol (DON), an important mycotoxin from the trichothecene family, is abundant in animal feed. Mycotoxin binders such as Lactic acid bacteria (LAB) detoxify mycotoxins by adsorption and inactivate the toxins through the formation of mycotoxin‐organic adsorbent complex or act as biomarkers to convert the toxins into less toxic products. In this study, the effect of organic adsorbent containing Lactobacillus strains and the cell wall of the yeast Saccharomyces cerevisiae was investigated on the reduction of DON. Various parameters including toxin concentration, adsorbent type, incubation time, and the synergism effect were also studied. The detoxification ability was demonstrated in all strains but the combination of Lactobacillus brevis TD4 and Lactobacillus paracasei TD3 in PBS solution and L. brevis TD4 and L. brevis TD10 in MRS broth medium showed the highest reduction rate of DON. Novelty Impact Statement Deoxynivalenol causes devastating effects on animal health as well as agricultural products such as decreased milk yield and lower quality of dairy products. In the current study, the detoxification ability of mycotoxin‐organic binders including Lactobacillus and yeast cell wall was investigated and the combination of Lactobacillus brevis TD4 and Lactobacillus paracasei TD3 in PBS solution and L. brevis TD4 and L. brevis TD10 in MRS broth medium showed the highest reduction rate of DON.
- 31 December 2020
- Published by Hindawi Limited in Journal of Food Processing and Preservation
- Vol. 45 (3)
In vitro reduction of mycotoxin deoxynivalenol by organic adsorbent
The contamination of feeds and foods with mycotoxins is a serious problem worldwide. Deoxynivalenol (DON), an important mycotoxin from the trichothecene family, is abundant in animal feed. Mycotoxin binders such as Lactic acid bacteria (LAB) detoxify mycotoxins by adsorption and inactivate the toxins through the formation of mycotoxin‐organic adsorbent complex or act as biomarkers to convert the toxins into less toxic products. In this study, the effect of organic adsorbent containing Lactobacillus strains and the cell wall of the yeast Saccharomyces cerevisiae was investigated on the reduction of DON. Various parameters including toxin concentration, adsorbent type, incubation time, and the synergism effect were also studied. The detoxification ability was demonstrated in all strains but the combination of Lactobacillus brevis TD4 and Lactobacillus paracasei TD3 in PBS solution and L. brevis TD4 and L. brevis TD10 in MRS broth medium showed the highest reduction rate of DON. Novelty Impact Statement Deoxynivalenol causes devastating effects on animal health as well as agricultural products such as decreased milk yield and lower quality of dairy products. In the current study, the detoxification ability of mycotoxin‐organic binders including Lactobacillus and yeast cell wall was investigated and the combination of Lactobacillus brevis TD4 and Lactobacillus paracasei TD3 in PBS solution and L. brevis TD4 and L. brevis TD10 in MRS broth medium showed the highest reduction rate of DON.